Poxel (LTS:0RA2) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


LTS:0RA2 Poxel SA LTS:0RA2
42 GF Score
Price €0.20
GF Value €1.21
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Poxel Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Poxel's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

LTS:0RA2 vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Poxel's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poxel Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poxel's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Poxel's Margin of Safety % (DCF FCF Based) falls into.


LTS:0RA2
42GF Score
Poxel SA LTS:0RA2
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Poxel (LTS:0RA2) Overvalued in 2026?

Based on GuruFocus' analysis, Poxel stock appears to be undervalued. The current stock price of €0.20 is trading 83.2% below its estimated GF Value™ of €1.21. GuruFocus considers Poxel to be Possible Value Trap.

Key valuation signals for LTS:0RA2:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €1.21 vs. price of €0.20 (83.2% below fair value)
  • GF Score™: 42/100 with 6 warning signs

No single metric tells the full story. See the LTS:0RA2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Poxel Business Description

Other Exchanges POXEL:France7PO:Germany
Address 259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.
42GF Score

Get the complete analysis for LTS:0RA2

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.20
Price
€1.21
GF Value